Abstract

P-032 - FOLFIRINOX versus gemcitabine-cisplatin combination as first line therapy in treatment of pancreatic cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Development of the gemcitabine-based first-line therapies for pancreatic cancer
...
-
, et. al. ...
01 Apr 2016
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
Michele Reni ... Valerio Di Carlo
Lancet Oncology | VOL. 6
Michele Reni, et. al.Michele Reni ... Valerio Di Carlo
10 May 2005
Concepts of lines of therapy in cancer treatment: findings from an expert interview-based study
Lisa Falchetto ... Daniel Maier
BMC research notes | VOL. 17
Lisa Falchetto, et. al.Lisa Falchetto ... Daniel Maier
15 May 2024
Abstract 3695: Efficacy of gemcitabine combined with hyperthermia therapy in the treatment of unresectable pancreatic cancer: Phase II study
Reiko Tsuchiya ... Tatsuzo Matsuyama
American Journal of Cancer | VOL. 72
Reiko Tsuchiya, et. al.Reiko Tsuchiya ... Tatsuzo Matsuyama
15 Apr 2012
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Efficacy of TIL Therapy in Advanced Cutaneous Melanoma in the Current Immuno-oncology Era: Updated Systematic Review and Meta-analysis
S Martín-Lluesma ... G Coukos
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
S Martín-Lluesma, et. al.S Martín-Lluesma ... G Coukos
23 Jul 2024
Exploiting the tumor microenvironment and tumor mechanobiology for the treatment of cancer cachexia
Kostas A Papavassiliou ... Athanasios G Papavassiliou
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Kostas A Papavassiliou, et. al.Kostas A Papavassiliou ... Athanasios G Papavassiliou
23 Jul 2024
Immune Checkpoint Inhibitors in Endometrial Cancer: A Cinderella Story
N Colombo ... M Jalving
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
N Colombo, et. al.N Colombo ... M Jalving
22 Jul 2024
Overall survival in first-line HR+/HER2- advanced breast cancer in the era of CDK4/6 inhibitors
Rodrigo Sánchez-Bayona ... Mafalda Oliveira
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
Rodrigo Sánchez-Bayona, et. al.Rodrigo Sánchez-Bayona ... Mafalda Oliveira
22 Jul 2024
View more papers